CRISPR/Cas9 technology introduced two loxP sites flanking exons 2-4. Both loxP sites were inserted into nonconserved regions of intron 2-3 and intron 4-5 to minimize the possibility of disruption of gene expression. (J:299900)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count